Delivery of Care
Berlin pilot project brings precision care to the peripheries
An innovative network in Germany is giving men with advanced prostate cancer access to cutting-edge precision medicine – even if they live in remote areas. Patient organisations are wondering whether…
EMA at 25: learning more from cancer patients
The European Medicines Agency is 25 years old this year. To mark the occasion, the agency invited leading voices from parts of the cancer community to share their perspectives on…
Their fingers on the button: why neglecting radiation therapists is no longer an option
Can you be sure that the person who positions you on the radiotherapy table and delivers your prescribed dose has received the necessary training and education? Europe’s radiation therapist profession…
Delivering cancer care during the pandemic: lessons from the ‘first wave’
As the COVID-19 pandemic shows signs of an autumn resurgence, we look at how the ‘first wave’ impacted on the delivery of cancer care, and review responses to the Cancer…
Raed Al Dieri: Taking pathology from bit part to key player on the European oncology scene
With precision medicine, pathology has moved out of the labs and into the heart of clinical decision making. But the discipline still struggles to make its voice heard at the…
Will artificial intelligence revolutionise cancer therapeutics and care?
AI has started to impact oncology, with tools for quicker and more-accurate diagnostics, but its role in better interpreting genomic data is still to be realised. Rachel Brazil pinpoints the…
Prognostic biomarkers: could they help doctors, patients and families to better navigate the end of life?
“We had to explain that the reason she had broken her hip was because she was getting weaker and essentially dying… At that stage knowing whether Mum had days or…
Rare cancer care: Are European Reference Networks delivering on the promise?
With a bigger role for European Reference Networks foreseen for Europe’s post-pandemic future, we ask: are they fulfilling their mandate to improve the quality of diagnostics and care for patients…
Consequences of the COVID-19 pandemic on cancer patients
The coronavirus pandemic is increasing the risk that cancer gets ‘left behind’. According to data and estimates from Europe and the US, extreme pressure on healthcare systems is impacting heavily…
MDT meetings: why patient care suffers if I’m not there
Multidisciplinary team meetings should be where the full details of a patient’s cancer diagnosis are discussed by specialists with the cutting-edge knowledge and expertise in treating cancer and the relevant…